We’re delighted to announce that a letter highlighting the clinical need and importance of the TIPAL trial, titled Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?, has now been published in the American Journal of Respiratory and Critical Care Medicine.
Congratulations to authors Louise E Crowley, Andrew Wilson and David R Thickett!